---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-018638"
form_type: "8-K"
ticker: "BJDX"
cik: "0001704287"
company_name: "Bluejay Diagnostics, Inc."
filed_at: "2026-02-20T23:59:59+00:00"
generated_at: "2026-05-16T01:29:46.102593+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Bluejay Diagnostics: All prefunded warrants exercised; ~972K shares outstanding; 1.5M warrants at $7+

## Summary
- All prefunded warrants from Oct 2025 private placement fully exercised as of Feb 19, 2026.
- Common shares outstanding now ~972,000; no remaining prefunded warrants of any class.
- Cash-exercisable warrants for ~1.5M shares outstanding, exercise price $7.00 or greater.
- Notes recent 13G filings may not reflect 1-for-4 reverse split (Jan 29, 2026), overstating beneficial ownership.

## SEC filing metadata
- accession: 0001213900-26-018638
- form_type: 8-K
- ticker: BJDX
- cik: 0001704287
- company_name: Bluejay Diagnostics, Inc.
- filed_at: 2026-02-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1704287/000121390026018638/0001213900-26-018638-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1704287/000121390026018638/ea0277823-8k_bluejay.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-018638
- JSON: https://secwatch.observer/filing/0001213900-26-018638.json
- Plain text: https://secwatch.observer/filing/0001213900-26-018638.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.